KPTI filings
Corporate insider profile
Reshma Rangwala Filing Activity
Latest reported as EVP & Chief Medical Officer of Karyopharm Therapeutics Inc. (KPTI).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$7,890.06
- Latest transaction
- May 14, 2026
Affiliated corporations
Reported company relationships
Transaction history